| Literature DB >> 29695455 |
Michela Frascoli1,2, Lacy Coniglio1,2, Russell Witt1,2, Cerine Jeanty1,2, Shannon Fleck-Derderian3, Dana E Myers4, Tzong-Hae Lee5, Sheila Keating5, Michael P Busch5, Philip J Norris5, Qizhi Tang2, Giovanna Cruz6, Lisa F Barcellos6, Nardhy Gomez-Lopez7,8,9, Roberto Romero7,10,11,12, Tippi C MacKenzie13,2,14.
Abstract
Healthy pregnancy is the most successful form of graft tolerance, whereas preterm labor (PTL) may represent a breakdown in maternal-fetal tolerance. Although maternal immune responses have been implicated in pregnancy complications, fetal immune responses against maternal antigens are often not considered. To examine the fetal immune system in the relevant clinical setting, we analyzed maternal and cord blood in patients with PTL and healthy term controls. We report here that the cord blood of preterm infants has higher amounts of inflammatory cytokines and a greater activation of dendritic cells. Moreover, preterm cord blood is characterized by the presence of a population of central memory cells with a type 1 T helper phenotype, which is absent in term infants, and an increase in maternal microchimerism. T cells from preterm infants mount a robust proliferative, proinflammatory response to maternal antigens compared to term infants yet fail to respond to third-party antigens. Furthermore, we show that T cells from preterm infants stimulate uterine myometrial contractility through interferon-γ and tumor necrosis factor-α. In parallel, we found that adoptive transfer of activated T cells directly into mouse fetuses resulted in pregnancy loss. Our findings indicate that fetal inflammation and rejection of maternal antigens can contribute to the signaling cascade that promotes uterine contractility and that aberrant fetal immune responses should be considered in the pathogenesis of PTL.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29695455 PMCID: PMC6449052 DOI: 10.1126/scitranslmed.aan2263
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956